Nanocarriers for siRNA delivery to overcome cancer multidrug resistance

11Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Multidrug resistance (MDR) is an extremely complexed phenomenon in tumor chemotherapy and is one of the major obstacles for successful treatment. Discovery of RNA interference (RNAi) offers a new strategy with great potential to reverse MDR. Specific genes, which contribute to the emerging of MDR, can be silenced by RNAi. However, many natural barriers have to be overcome for efficient and safe delivery of siRNA. In recent years, the various kinds of nanocarriers, such as liposomes, cationic polymers, and inorganic materials, have been developed to deliver siRNA and show good results in reversing MDR. This review mainly summarizes the barriers in siRNA delivery and recent progress in designing nanotechnology-based siRNA delivery systems to overcome tumor MDR. © 2013 The Author(s).

Cite

CITATION STYLE

APA

Meng, Q. S., Yin, Q., & Li, Y. P. (2013, November). Nanocarriers for siRNA delivery to overcome cancer multidrug resistance. Chinese Science Bulletin. https://doi.org/10.1007/s11434-013-6030-9

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free